Hjem › Krampeanfall › Illinois
Kliniske studier for Krampeanfall i Illinois
8 studier for Krampeanfall søker deltakere på steder i Illinois.
Byer i Illinois
Offisiell studietekst (engelsk)
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Re:Cognition Health, Chicago
RekruttererFase 3
Alder 2 til 55 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05066217A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
- Northwestern University, Chicago
RekruttererFase 1
Alder 12 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07233239RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Southern Illinois University School of Medicine, Springfield
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06798896Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Re:Cognition Health-Chicago, Chicago
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07594119Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RekruttererObservasjonsstudie
Opp til 26 år · Alle kjønn · Oppdatert 6. aug. 2026 · NCT05374824A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Praxis Research Site, Chicago
RekruttererFase 3
1 Day – 18 Years · Alle kjønn · Oppdatert 3. aug. 2026 · NCT07019922Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 9. jun. 2026 · NCT05135091A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Southern Illinois University School of Medicine, Springfield
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 14. mai 2026 · NCT05716100Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.